When you choose to publish with PLOS, your research makes an impact. Make your work accessible to all, without restrictions, and accelerate scientific discovery with options like preprints and published peer review that make your work more Open.

collection

Cancer Metastasis

Calls for Papers Collections

Cancer metastasis is responsible for 90% of all cancer deaths. The metastatic cascade is a multistep and sequential process involving cancer cell invasion, intravasation, circulation and colonization. However, our knowledge of the molecular and biochemical mechanisms that govern this process are still poorly understood. Furthermore, there is an urgent need to develop therapeutic interventions that target each part of the cascade. In this Call for Papers, we are inviting submissions that report on the biochemical and cell biological basis of metastasis, including but not limited to cell adhesion, cell migration, cytoskeletal dynamics, cell polarity, tumour heterogeneity, tumour dormancy and the tumour microenvironment. In addition, we welcome submissions that report on disease progression and outcomes, potential biomarkers for metastatic cancer as well as the development of anti-metastatic therapies, including drug development, drug delivery and personalized medicine. In this collection, we aim to highlight the diversity of research that is being conducted in the cancer metastasis field, including studies that focus on basic and translational research.

Image Credit: Flickr

Guest Editors
  • Joe Ramos
  • Shengyu Yang
  • Helen Fillmore
  • Tobias Zech
PLOS ONE Collection
Read the original Call for Papers

PLOS announced the Antimicrobial Resistance Call for Papers on March 2020

Read the call here
View our other Calls for Papers 

PLOS offers a variety of Calls for Papers where selected articles are included in a published Collection. Find out if any of our Calls are relevant to your research.

click here to view our active calls for papers
Follow PLOS on Twitter

To keep up to date on the latest research.

follow us
Back to top